You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vitamin K Antagonist

Showing 1 - 25 of 8,812
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments

Completed
  • Hemophilia A
  • +2 more
  • Vitamin K Antagonist - Drug
  • Brest, France
  • +5 more
Apr 6, 2023

Antiphospholipid Syndrome, Arterial Thrombosis Trial in Buenos Aires, Córdoba, Hamilton (Dual antiplatelet therapy, Combined

Recruiting
  • Antiphospholipid Syndrome
  • Arterial Thrombosis
  • Dual antiplatelet therapy
  • +3 more
  • Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
  • +2 more
Dec 12, 2022

AORTIC VALVE DISEASES, Thromboembolism Trial in Korea, Republic of (Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin))

Recruiting
  • AORTIC VALVE DISEASES
  • Thromboembolism
  • Rivaroxaban Oral Tablet
  • Vitamin K antagonist(warfarin)
  • Bucheon, Korea, Republic of
  • +8 more
Oct 11, 2022

Non-vitamin K Antagonist Oral Anticoagulant Concentration and

Recruiting
  • Atrial Fibrillation
  • Data collection
  • Taipei, Please Select, Taiwan
  • +1 more
Apr 17, 2022

Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)

Completed
  • Intracerebral Hemorrhage
  • Tranexamic acid
  • Saline 0.9%
  • Basel, Switzerland
    Stroke Center, University Hospital Basel
Mar 22, 2022

Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)

Recruiting
  • Ischemic Stroke
  • Anticoagulant Adverse Reaction
  • Dabigatran, rivaroxaban, apixaban, edoxaban
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 22, 2023

Different Antithrombotic Therapy for Treatment of Ventricular

Recruiting
  • Ventricular Thrombus
  • non-vitamin K antagonist oral anticoagulants (NOACs)
  • +3 more
  • Beijing, China
    Qing Yang
Jul 11, 2022

CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )

Active, not recruiting
  • CTEPH
  • Fukuoka, Japan
    Kyushu University Hospital
Aug 30, 2022

Real Life of New Oral Anticoagulants and Vitamin K Antagonists

Completed
  • Atrial Fibrillation
  • Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
  • Vitamin K antagonist: warfarin, fluindione, acenocoumarol
  • Paris, France
    Assistance Publique Hôpitaux de Paris
Mar 28, 2022

Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute

Recruiting
  • Therapeutic Drug Monitoring
  • Blood sampling to test drug level
  • Taipei, Taiwan
    National Taiwan University Hospital
Mar 8, 2022

Nonvalvular Atrial Fibrillation Trial in Angers (Rivaroxaban 20 MG, Warfarin)

Recruiting
  • Nonvalvular Atrial Fibrillation
  • Angers, France
    Angers University Hospital
Jul 25, 2022

NOACs Use in AF or VTE (SUNSHINE Registry)

Recruiting
  • Atrial Fibrillation
  • +2 more
  • Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE)
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jun 6, 2022

Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)

Not yet recruiting
  • Intra-cardiac Thrombus
  • +2 more
  • Vitamin K antagonist
  • Direct oral anticoagulant
  • Angers, France
  • +33 more
Apr 11, 2023

Atrial High Rate Episodes Trial in Multiple Locations (Edoxaban, ASA)

Recruiting
  • Atrial High Rate Episodes
  • Multiple Locations, Austria
  • +16 more
Jun 3, 2022

Incorporation of Protein Induced by Vitamin K Absence or

Completed
  • Cancer of Liver
  • No intervention
  • Hangzhou, Zhejiang, China
    Affiliated Hangzhou First People's Hospital, Zhejiang University
Jun 8, 2023

Gather Information About Rivaroxaban in Sweden With Cancer Who

Active, not recruiting
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +3 more
  • Multiple Locations, Many Locations, Sweden
    Swedish registries
Aug 18, 2022

Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,

Not yet recruiting
  • Kawasaki Disease
  • +4 more
  • Rivaroxaban Oral Tablet or Suspension [Xarelto]
  • +2 more
  • (no location specified)
Dec 6, 2022

Anticoagulants in Patients With Venous Thromboembolism in Korea

Completed
  • Venous Thromboembolism
  • Parenteral anticoagulant
  • +5 more
  • Seongnam-si, Korea, Republic of
  • +1 more
May 20, 2022

Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin

Completed
  • Venous Thromboembolism
  • +3 more
  • Rivaroxaban 20 MG [Xarelto]
  • +2 more
  • Metepec, Estado De Mexico, Mexico
    Instituto Mexicano Del Seguro Social
Aug 24, 2022

Stroke and Systemic Embolism in Atrial Fibrillation in Real-Life

Completed
  • Anticoagulation
  • Rueil-malmaison Cedex, France
    (unnamed)
May 16, 2022

Healthy Volunteers Trial in Groningen (Cofact)

Recruiting
  • Healthy Volunteers
  • Cofact
  • Groningen, Netherlands
    PRA Health Sciences
Jan 12, 2022

Atrial Fibrillation, Coronary Artery Disease Trial in Athens (VKA, NOAC)

Completed
  • Atrial Fibrillation
  • Coronary Artery Disease
  • Athens, Attika, Greece
    Attikon University Hospital
Jul 23, 2021

Thromboembolic Events in Patients Receiving Kcentra® or Plasma

Completed
  • Hemorrhage
  • Kcentra®
  • Plasma
  • Oakland, California
    Study Site
May 24, 2021

Thrombosis Trial in Worldwide (Apixaban, Vitamin K Antagonist (VKA), Low Molecular Weight Heparin (LMWH))

Completed
Has Results
  • Thrombosis
  • Phoenix, Arizona
  • +45 more
Sep 29, 2022

Learn More About Benefits and Side-effects of Drugs Rivaroxaban

Completed
  • Atrial Fibrillation
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Many Sites, United Kingdom
    Many facilities
Oct 27, 2021